| Unique ID issued by UMIN | UMIN000054133 |
|---|---|
| Receipt number | R000061463 |
| Scientific Title | Examination of the novel system of Training Device for Elderly People. |
| Date of disclosure of the study information | 2024/05/31 |
| Last modified on | 2025/08/05 09:19:11 |
Examination of the novel system of Training Device for Elderly People.
Examination of the novel system of Training Device for Elderly People.
Examination of the novel system of Training Device for Elderly People.
Examination of the novel system of Training Device for Elderly People.
| Japan |
Healthy elderly people
| Not applicable |
Others
NO
Evaluating the safety of Exercise Coach Muscle Training Device for elderly people.
Safety
Adverse events
Muscle strength
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
| Device,equipment |
Muscle Strength training using the Exercise Coach muscle training device
| 65 | years-old | <= |
| 80 | years-old | > |
Male and Female
(1) Individuals aged 65 or older but younger than 80 at the time of consent.
(2) Individuals who, within the past 3 months, have consistently demonstrated systolic blood pressure below 150mmHg and diastolic blood pressure below 100mmHg through regular measurements at medical facilities or self-monitoring at home (including those taking antihypertensive medication).
(3) Individuals currently free from symptoms such as joint pain, muscle pain, or bone pain that could affect their ability to exercise.
(4) Individuals who have provided written informed consent for participation in this study of their own free will.
(1) Individuals currently experiencing musculoskeletal disorders or pain in the musculoskeletal system.
(2) Individuals with a history of myocardial infarction, angina pectoris, heart failure, aortic aneurysm, aortic dissection, or valvular heart disease.
(3) Individuals diagnosed with severe mental disorders requiring treatment (e.g., schizophrenia, severe depression, bipolar disorder) or dementia.
(4) Individuals with significantly impaired basic visual or auditory functions necessary for communication or understanding research instructions.
(5) Individuals with active liver disease or progressive kidney disease (e.g., cirrhosis, chronic renal failure).
(6) Individuals diagnosed with malignant tumors within the past 5 years or currently undergoing treatment, excluding adequately treated non-invasive skin cancers (such as basal cell carcinoma or squamous cell carcinoma).
(7) Individuals diagnosed with substance abuse or alcohol dependence within the past year or currently undergoing treatment.
(8) Other individuals deemed unsuitable for this study by the study personnel.
20
| 1st name | Yoshitada |
| Middle name | |
| Last name | Sakai |
Kobe University Graduate School of Medicine
Division of Rehabilitation Medicine
650-0017
7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan
0783826826
yossie@med.kobe-u.ac.jp
| 1st name | Yoshitada |
| Middle name | |
| Last name | Sakai |
Kobe University Graduate School of Medicine
Division of Rehabilitation Medicine
650-0017
7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japa
0783826826
yossie@med.kobe-u.ac.jp
Kobe University
Kobe University
Self funding
Kobe University Graduate School of Medicine
7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan
0783826826
yossie@med.kobe-u.ac.jp
NO
| 2024 | Year | 05 | Month | 31 | Day |
Unpublished
18
No serious adverse events were observed.
| 2025 | Year | 08 | Month | 05 | Day |
Completed
| 2024 | Year | 05 | Month | 01 | Day |
| 2024 | Year | 06 | Month | 21 | Day |
| 2024 | Year | 11 | Month | 26 | Day |
| 2025 | Year | 07 | Month | 31 | Day |
| 2025 | Year | 07 | Month | 31 | Day |
| 2025 | Year | 07 | Month | 31 | Day |
| 2024 | Year | 04 | Month | 12 | Day |
| 2025 | Year | 08 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061463